HER-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder
- 30 April 2004
- journal article
- Published by Elsevier BV in Urology
- Vol. 63 (4), 786-790
- https://doi.org/10.1016/j.urology.2003.10.040
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- HER2 overexpression in muscle‐invasive urothelial carcinoma of the bladder: Prognostic implicationsInternational Journal of Cancer, 2002
- Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma?Cancer, 2002
- HER-2 - A Possible Target for Therapy of Metastatic Urinary Bladder CarcinomaActa Oncologica, 2002
- Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2New England Journal of Medicine, 2001
- Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression of invasive bladder cancerUrological Research, 1997
- Prevalence and Clinical Significance of Her-2/neu, p53 and Rb Expression in Primary Superficial Bladder CancerJournal of Urology, 1996
- C-ERBB-2 in Bladder Cancer: Molecular Biology, Correlation with Epidermal Growth Factor Receptors and Prognostic ValueJournal of Urology, 1996
- An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinomaCancer, 1992
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptorNature, 1986